Unlocking the potential of the intellectual property in your research

Written by UMIP on . Posted in News


IPO image







Register Now: https://ipo-unlocking-potential.eventbrite.co.uk

Date: Tuesday 21st March

Time: 12:00 – 16:30

Location: The University of Manchester Innovation Centre (UMIC), The Core Technology Facility, 46 Grafton Street, Manchester, M13 9NT.

Who? All PhD students and Early Career Researchers from across the N8 Partnership universities.

Can you take your research further? By drawing on the expertise of IP professionals and the experience of those who have successfully navigated the knowledge exchange landscape you will learn how to develop an IP strategy to support the outcomes of your research.

The workshop will include:

·         Overview of IP rights and IP strategies delivered by the IPO and IP specialists HGF

·         The options available to translate your IP from research to impact

·         Case studies on managing research generated IP through the knowledge exchange and commercialisation process

·         A hands-on session to develop an IP strategy

·         A networking lunch

ipo 2

University of Manchester technology set to reduce the cost of environmentally friendly biochemicals

Written by UMIP on . Posted in News

Ben DolmanA PhD student has created a technology which could enable multi-national companies to reduce the cost of replacing petroleum based surfactants, fuels and other chemicals with environmentally friendly biosurfactants and biologically produced fuels and chemicals.

Ben Dolman studies biochemical engineering at The University of Manchester under the supervision of Dr James Winterburn, and his technology, which separates biochemicals as they are produced by fermentation, has so far been demonstrated with sophorolipid biosurfactants.


It could also be applied to other insoluble biochemicals produced for use as fuels, as industrial chemicals and in personal care, such as terponoids and MELs.

At present, sophorolipids are used in laundry detergents, dishwasher detergents and personal care products, while production costs still limit production for bulk applications such as bioremediation (the clean-up of oil spills and other pollutants).

Ben commented: “By facilitating around double the production of sophorolipids per batch, as well as reducing energy and separation costs, this technology has the potential to dramatically reduce production costs and so expand the use of these environmentally friendly chemicals.”

The 26-year-old has been working closely with The University of Manchester’s agent for intellectual property commercialisation UMIP over the past 12 months, and says he always knew his idea had commercial potential.

“With a rapidly expanding market for biochemicals and sophorolipids in particular, this separation technology provides a promising opportunity to reduce costs and expand into the bulk chemicals sector,” said Ben.

“The simplicity of the design, combined with the possibility to easily retrofit the separator to existing processes, means the technology can be quickly implemented with minimal costs.”

Ben now plans to demonstrate this technology with other bioproducts and at scale.

“Now that we have demonstrated the capacity of this technology to recover sophorolipids, having filed a patent and published a paper on the work, we are looking to expand the scope of this project,” he said.

“This technology should be applicable to most insoluble or partially soluble bioproducts, and we have planned to develop this aspect in the coming months as well as scale up the separator and develop automated control systems.”

Ben would love to hear from any interested parties, and can be contacted through UMIP or his university profile. Further information can also be found at the following links;



Stroke Association Priority Programme Award in Haemorrhagic Stroke

Written by UMIP on . Posted in News

Priority Programme Award:

  • Award amount: up to £450,000 for a period of 3 to 5 years.
  • Deadline for Expression of Interest forms: 5PM on 1 March 2017.
  • After this date,  prospective applicants will be emailed with the full application forms for completion by 1st June 2017.
  • Please Note: applications from those who did not register an Expression of Interest for this call will not be accepted.


For further information please see Stroke Association Haemorrhagic Stroke Priority Programme Award

MRC Confidence in Concept (CiC) scheme now open: Information event 15th February 2017

Written by UMIP on . Posted in News

The University has secured funding from the fifth round of the MRC Confidence in Concept (CiC) scheme. An information event for CiC 2017 has been scheduled for 15th February to share experience from the previous rounds of the programme and provide guidance to potential applicants on how to prepare a competitive CiC proposal. The event will include an overview of the scheme, an industry perspective on the programme and details about the process for applications this year. The meeting will end with a networking session and the opportunity to get advice on your CiC proposal ideas from FBMH Strategic Funding Team colleagues and an industry perspective from Dr John Stageman, BioNow.

Information event registration

Via Eventbrite: https://www.eventbrite.co.uk/e/mrc-confidence-in-concept-cic-phase-5-launch-event-wed-15th-feb-2015-11am-2pm-registration-31538835506

Indicative agenda

11.00am Introduction: Dr Graham Cadwallader, Strategic Funding Team

11.10am Process, timelines and guidance for the CiC 2015 Programme: Anu Suokas, UoM/CiC Programme Manager, Strategic Funding Team

11.25am CiC and DPFS Schemes: MRC representative (TBC)

11.45am Industry perspective on the CiC programme: Dr. John Stageman, Bionow

12noon-2pm Lunch, networking and advice session (15 minute advice slots will be available)

MRC Confidence in Concept (CiC) scheme 2017: Call details The call is now open, EoI deadline: 10am Friday 24th February 2017.

Full guidance about the call and the application process.

Manchester Molecular Pathology Innovation Centre – Annual Symposium 9th March 2017 (12.30 – 17.00 )

Written by UMIP on . Posted in News

Manchester Molecular Pathology Innovation Centre is one of six molecular pathology nodes funded by MRC and EPSRC to facilitate the translation of stratified medicine discovery to biomarker-based tests in the clinic for patient benefit.


You are warmly invited to the MMPathIC Annual Symposium 2017 which will provide an update on current activities, future strategy, and the opportunities available to researchers, clinicians and industry-

  • WHERE:  Citylabs, Nelson Street, M13 9NQ
  • WHEN:    Thursday 9th March (Starting with lunch from ~12:30pm, until ~17:00, finishing with a networking wine reception
  • WHAT:   An update on MMPathIC’s activities over the past year and how the molecular pathology node fits with the local innovation infrastructure and industry needs.

There will be the opportunity to find out how you might benefit from the flexible funding and industry ecosystem which has been generated through the MMPathIC infrastructure

The agenda is still in development but will include (amongst others) speakers from the Stoller Biomarker Discovery Centre and Singulex, one of MMPathIC’s strategic industrial partners.

Please register here if you would like to attend- https://www.eventbrite.co.uk/e/manchester-molecular-pathology-innovation-centre-mmpathic-annual-symposium-2017-tickets-31593021578

Please feel free to circulate to interested colleagues in your respective areas.


Privacy Policy / Terms and Conditions / © Copyright 2015 The University of Manchester Intellectual Property / Created by HTP Digital Marketing Agency

The University of Manchester Intellectual Property ("UMIP") acts solely as agent for the University in relation to any matter relating to intellectual property ("IP") and know how created at the University. This is whether such IP is created by employees, students or others. UMIP does not represent anyone else in such matters. If anyone else requires advice in relation to such IP then they must take their own independent legal advice.